Piramal Pharma (PPL), a subsidiary of Piramal Enterprises, has agreed to acquire 100% stake in Indian peptide APIs manufacturer Hemmo Pharmaceuticals, for $105.6m (INR7.75bn). Upon completion of the
The post Piramal to acquire APIs manufacturer Hemmo Pharmaceuticals appeared first on Pharmaceutical Business review.